Literature DB >> 32079286

Melanoma-Derived Exosomal miR-125b-5p Educates Tumor Associated Macrophages (TAMs) by Targeting Lysosomal Acid Lipase A (LIPA).

Dennis Gerloff1, Jana Lützkendorf2, Rose K C Moritz1, Tom Wersig3, Karsten Mäder3, Lutz P Müller2, Cord Sunderkötter1.   

Abstract

Tumor-associated macrophages (TAMs) are the most abundant immune cells in the tumor microenvironment, promoting tumor initiation, growth, progression, metastasis, and immune evasion. Recently it was shown that cancer cell-derived exosomes induce a tumor-promoting phenotype in TAMs. Exosome-loaded proteins, DNA, and RNAs may contribute to the macrophage reprogramming. However, the exact mediators and mechanisms, particularly in melanoma, are not known. In this study we examined the effects of cutaneous melanoma-derived exosomes on macrophage function and the underlying mechanisms. First, we showed that exposure to melanoma exosomes induces a tumor-promoting TAM phenotype in macrophages. Sequencing revealed enrichment for several miRNAs including miR-125b-5p in cutaneous melanoma exosomes. We showed that miR-125b-5p is delivered to macrophages by melanoma exosomes and partially induces the observed tumor-promoting TAM phenotype. Finally, we showed that miR-125b-5p targets the lysosomal acid lipase A (LIPA) in macrophages, which in turn contributes to their phenotype switch and promotes macrophage survival. Thus, our data show for the first time that miR-125b-5p transferred by cutaneous melanoma-derived exosomes induces a tumor-promoting TAM phenotype in macrophages.

Entities:  

Keywords:  exosomes; melanoma; miRNAs; tumor-associated macrophages

Year:  2020        PMID: 32079286     DOI: 10.3390/cancers12020464

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  33 in total

Review 1.  Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.

Authors:  Wenhao Li; Xiaolong Wang; Chen Li; Tong Chen; Qifeng Yang
Journal:  Mol Ther       Date:  2021-12-02       Impact factor: 11.454

Review 2.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

Review 3.  Exosomal non-coding RNAs have a significant effect on tumor metastasis.

Authors:  Di Wang; Wei Zhang; Chunxi Zhang; Liwei Wang; Heng Chen; Jianbin Xu
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-31       Impact factor: 10.183

Review 4.  The Role of Extracellular Vesicles in Melanoma Progression.

Authors:  Evelyn Lattmann; Mitchell P Levesque
Journal:  Cancers (Basel)       Date:  2022-06-23       Impact factor: 6.575

Review 5.  Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.

Authors:  Yingying Xing; Guojing Ruan; Haiwei Ni; Hai Qin; Simiao Chen; Xinyue Gu; Jiamin Shang; Yantong Zhou; Xi Tao; Lufeng Zheng
Journal:  Front Immunol       Date:  2021-05-18       Impact factor: 7.561

6.  The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer.

Authors:  Malgorzata Czystowska-Kuzmicz; Theresa L Whiteside
Journal:  Expert Opin Biol Ther       Date:  2020-09-08       Impact factor: 4.388

Review 7.  Metabolic Regulation of Macrophage Activation.

Authors:  Ourania Kolliniati; Eleftheria Ieronymaki; Eleni Vergadi; Christos Tsatsanis
Journal:  J Innate Immun       Date:  2021-07-09       Impact factor: 7.349

8.  Molecular Mechanisms of PD-1 and PD-L1 Activity on a Pan-Cancer Basis: A Bioinformatic Exploratory Study.

Authors:  Siddarth Kannan; Geraldine Martina O'Connor; Emyr Yosef Bakker
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

9.  FUT8-AS1 Inhibits the Malignancy of Melanoma Through Promoting miR-145-5p Biogenesis and Suppressing NRAS/MAPK Signaling.

Authors:  Xiang-Jun Chen; Sha Liu; Dong-Mei Han; De-Zhi Han; Wei-Jing Sun; Xiao-Chun Zhao; Jun-Qing Liang; Li Yu
Journal:  Front Oncol       Date:  2021-05-19       Impact factor: 6.244

Review 10.  Exosomes as mediators of immune regulation and immunotherapy in cancer.

Authors:  Fernanda G Kugeratski; Raghu Kalluri
Journal:  FEBS J       Date:  2020-10-03       Impact factor: 5.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.